5 assets in Primary Progressive Aphasia

Therapeutic assets addressing Primary Progressive Aphasia, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Flortaucipir Primary Progressive Aphasia	Mayo Clinic	P4	BBB (72)
Nabilone Primary Progressive Aphasia	Simon Ducharme, MD	P2	CCC (53)
Pittsburgh Compound B Unlabelled Primary Progressive Aphasia	Mayo Clinic	P1	CC (47)
Apsolol Primary Progressive Aphasia	University of Missouri-Columbia	Early P1	C (39)